Access cutting-edge breast cancer treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This is a post-marketing single arm, phase IV trial in which patients with high-risk early-stage HR+HER2- breast cancer will receive adjuvant abemaciclib in combination with endocrine therapy (ET) After study intervention, participants will remain on combination abemaciclib + ET at the discretion of their treating providers
Sponsor: University of Illinois at Chicago
Check if you qualify for this breast cancer clinical trial in Chicago, IL
If you're searching for breast cancer treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.